ask="9.77"
ask_size="200"
average_daily_volume="165582"
bid="4.15"
bid_size="100"
book_value="7.07"
change="+0.18"
change_from_200_day_moving_average="6.72"
change_from_50_day_moving_average="3.05"
change_from_52_week_high="-0.17"
change_From_52_week_low="3.40"
change_in_percent="+1.93%"
close="9.50"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="-15.57M"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="7983000"
high="9.67"
high_52_weeks="9.67"
last_trade_date="1/20/2017"
last_trade_price="9.50"
last_trade_size="205"
last_trade_time="4:00pm"
low="9.19"
low_52_weeks="6.10"
market_capitalization="100.37M"
moving_average_200_day="2.78"
moving_average_50_day="6.45"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.50"
open="9.35"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="+241.52%"
percent_change_from_50_day_moving_average="+47.39%"
percent_change_from_52_week_high="-1.76%"
percent_change_from_52_week_low="+55.74%"
previous_close="9.32"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.32"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="10565000"
short_ratio="1.23"
stock_exchange="NMS"
symbol="NVLN"
volume="71854"
weeks_range_52="6.10 - 9.67"
